Charles Schwab Investment Management Inc Verrica Pharmaceuticals Inc. Call Options Transaction History
Charles Schwab Investment Management Inc
- $429 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding VRCA
# of Institutions
62Shares Held
16.2MCall Options Held
0Put Options Held
0-
Perceptive Advisors LLC New York, NY7.1MShares$56.4 Million0.88% of portfolio
-
Avoro Capital Advisors LLC New York, NY4MShares$31.8 Million0.29% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.27MShares$10.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.11MShares$8.86 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA449KShares$3.57 Million0.0% of portfolio
About Verrica Pharmaceuticals Inc.
- Ticker VRCA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,094,100
- Market Cap $327M
- Description
- Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...